Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main
Syed Yaseen Naqvi1, Jordan Klein1, Tisa Saha1
1Department of Internal Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, Pennsylvania.
Insights
Percutaneous coronary intervention (PCI) is now a viable alternative to coronary artery bypass grafting (CABG) for left main (LM) coronary artery disease. Advances in PCI techniques and devices have improved outcomes for selected patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Surgery
Background:
- Coronary artery bypass grafting (CABG) was the standard treatment for significant left main (LM) coronary artery disease.
- Percutaneous coronary intervention (PCI) has emerged as a competitive alternative.
- Patient selection and procedural advancements are key to successful PCI.
Purpose of the Study:
- To review the current management strategies for unprotected LM disease.
- To compare the efficacy and safety of PCI versus CABG.
- To highlight recent advancements in PCI for LM lesions.
Main Methods:
- Review of observational registries and randomized controlled trials comparing PCI and CABG.
- Evaluation of physiological measures (e.g., fractional flow reserve) and intracoronary imaging (IVUS, OCT).
- Assessment of newer generation stents and specialized techniques for LM bifurcation stenting.
Main Results:
- PCI is safe and effective in appropriately selected patients with low or intermediate risk.
- Physiological measures and intracoronary imaging improve PCI outcomes.
- Advanced techniques and devices expand PCI applicability to complex LM lesions.
Conclusions:
- PCI is a valuable option for unprotected LM disease, offering an alternative to CABG.
- Continued research and randomized comparisons will refine treatment decisions.
- Heart teams play a crucial role in selecting the optimal revascularization strategy.
Abstract:
Coronary artery bypass grafting (CABG) decreases mortality in patients with significant left main (LM) coronary artery disease and for years remained the therapy of choice for patients with this ominous lesion. Advances in percutaneous coronary intervention (PCI) have enabled it to become an alternative to CABG. The results of observational registries and randomized comparisons have shown the safety and efficacy of PCI in appropriately selected patients with low or intermediate angiographic risk scores. Furthermore, the use of physiological measures of flow limitation and the use of intracoronary imaging techniques has added benefit and improved outcomes. The use of fractional flow reserve to more accurately evaluate the significance of intermediate lesions and guide the extent of revascularization has been an important refinement. Intravascular ultrasound and optical coherence tomography assessment of optimal stent deployment has led to reductions in restenosis. Newer generation stents, combined with improvements in specific techniques, especially at the LM bifurcation have extended PCI to more complex anatomic scenarios. The availability of left ventricular support devices in patients with complex coronary anatomy and severely depressed left ventricular function has added a margin of safety to LM and multivessel intervention. Randomized comparisons of CABG with PCI in carefully selected patients, using contemporaneous surgical and interventional techniques and optimal medical therapy, will further aid heart teams in the decision-making process. In conclusion, this review will give a concise overview of the management of unprotected LM disease.
Related Concept Videos
01:24Cardiac Catheterization III: Left Heart Catheterization
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care